Improved Intratumoral Oxygenation Through Vascular Normalization Increases Glioma Sensitivity to Ionizing Radiation

• Published in: International journal of radiation oncology, biology, physics Vol. 76; no. 5; pp. 1537 - 1545
• Main Authors: McGee, Mackenzie C., M.D, Hamner, J. Blair, M.D, Williams, Regan F., M.D, Rosati, Shannon F., M.D, Sims, Thomas L., M.D, Ng, Catherine Y., M.S, Gaber, M. Waleed, Ph.D, Calabrese, Christopher, Ph.D, Wu, Jianrong, Ph.D, Nathwani, Amit C., M.D., Ph.D, Duntsch, Christopher, M.D., Ph.D, Merchant, Thomas E., D.O., Ph.D, Davidoff, Andrew M., M.D
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-04-2010
• Subjects: Angiogenesis Inhibitors - pharmacology; Animals; ANOXIA; Antibodies, Monoclonal - pharmacology; Antibodies, Monoclonal, Humanized; Bevacizumab; Cell Hypoxia - drug effects; DISEASES; glioma; Glioma - blood supply; Glioma - metabolism; Glioma - radiotherapy; GLIOMAS; GROWTH; Hematology, Oncology and Palliative Medicine; Interferon-beta - pharmacology; interferon-β; ionizing radiation; IONIZING RADIATIONS; Male; Mice; Mice, SCID; NECROSIS; NEOPLASMS; Neovascularization, Pathologic - drug therapy; NERVOUS SYSTEM DISEASES; Oxygen Consumption - drug effects; oxygenation; PATHOLOGICAL CHANGES; Radiation Tolerance - drug effects; RADIATION, THERMAL, AND OTHER ENVIRONMENTAL POLLUTANT EFFECTS ON LIVING ORGANISMS AND BIOLOGICAL MATERIALS; RADIATIONS; Radiology; RADIOSENSITIVITY; SENSITIVITY; Transplantation, Heterologous; Vascular normalization; bevacizumab; glioma; Vascular normalization; oxygenation; interferon-β; ionizing radiation
• ISSN: 0360-3016; 1879-355X
• DOI: 10.1016/j.ijrobp.2009.12.010

Purpose Ionizing radiation, an important component of glioma therapy, is critically dependent on tumor oxygenation. However, gliomas are notable for areas of necrosis and hypoxia, which foster radioresistance. We hypothesized that pharmacologic manipulation of the typically dysfunctional tumor vasculature would improve intratumoral oxygenation and, thus, the antiglioma efficacy of ionizing radiation. Methods and Materials Orthotopic U87 xenografts were treated with either continuous interferon-β (IFN-β) or bevacizumab, alone, or combined with cranial irradiation (RT). Tumor growth was assessed by quantitative bioluminescence imaging; the tumor vasculature using immunohistochemical staining, and tumor oxygenation using hypoxyprobe staining. Results Both IFN-β and bevaziumab profoundly affected the tumor vasculature, albeit with different cellular phenotypes. IFN-β caused a doubling in the percentage of area of perivascular cell staining, and bevacizumab caused a rapid decrease in the percentage of area of endothelial cell staining. However, both agents increased intratumoral oxygenation, although with bevacizumab, the effect was transient, being lost by 5 days. Administration of IFN-β or bevacizumab before RT was significantly more effective than any of the three modalities as monotherapy or when RT was administered concomitantly with IFN-β or bevacizumab or 5 days after bevacizumab. Conclusion Bevacizumab and continuous delivery of IFN-β each induced significant changes in glioma vascular physiology, improving intratumoral oxygenation and enhancing the antitumor activity of ionizing radiation. Additional investigation into the use and timing of these and other agents that modify the vascular phenotype, combined with RT, is warranted to optimize cytotoxic activity.